These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26851819)

  • 21. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
    Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
    Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Histological classification of hepatocellular carcinoma].
    Kojiro M
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():203-15. PubMed ID: 11761942
    [No Abstract]   [Full Text] [Related]  

  • 23. Primary intrahepatic small-cell carcinoma arising from combined hepatocellular and cholangiocarcinomas.
    Khaw YL; Nolan N; Heaslip I; McCormick PA; Sheahan K
    J Clin Oncol; 2011 Jul; 29(21):e630-3. PubMed ID: 21606429
    [No Abstract]   [Full Text] [Related]  

  • 24. A resected case of combined hepatocellular carcinoma and cholangiocarcinoma associated with cystic formation.
    Utsunomiya T; Saitsu H; Saku M; Takeshita M; Yoshida K; Kajiyama K; Sugimachi K
    Hepatogastroenterology; 2000; 47(33):851-4. PubMed ID: 10919046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Review on the Update of Combined Hepatocellular Cholangiocarcinoma.
    Komuta M; Yeh MM
    Semin Liver Dis; 2020 May; 40(2):124-130. PubMed ID: 31887773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma.
    Wakasa T; Wakasa K; Shutou T; Hai S; Kubo S; Hirohashi K; Umeshita K; Monden M
    Hepatogastroenterology; 2007 Mar; 54(74):508-13. PubMed ID: 17523309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Zuo HQ; Yan LN; Zeng Y; Yang JY; Luo HZ; Liu JW; Zhou LX
    Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):161-5. PubMed ID: 17374575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Indications for liver biopsy in liver tumors].
    Stölzel U; Tannapfel A; Wittekind C; Hamm B; Schuppan D
    Dtsch Med Wochenschr; 2000 Sep; 125(36):1041-4. PubMed ID: 11022600
    [No Abstract]   [Full Text] [Related]  

  • 29. Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules.
    Kwon Y; Lee SK; Kim JS; Ro JY; Yu E
    Mod Pathol; 2002 Oct; 15(10):1096-101. PubMed ID: 12379757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Combined hepatocellular carcinoma and cholangiocellular carcinoma].
    Maeda Y; Nishida M; Mori N; Tamesa T; Okada T; Tangoku A; Oka M
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():401-5. PubMed ID: 11761981
    [No Abstract]   [Full Text] [Related]  

  • 31. Biliary tumor fragment of hepatocellular carcinoma containing lipiodol mimicking a bile duct stone.
    Matsumoto K; Osanai M; Maguchi H
    Dig Endosc; 2014 Mar; 26(2):295-6. PubMed ID: 24405219
    [No Abstract]   [Full Text] [Related]  

  • 32. Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma.
    Shetty AS; Fowler KJ; Brunt EM; Agarwal S; Narra VR; Menias CO
    Abdom Imaging; 2014 Apr; 39(2):310-22. PubMed ID: 24407728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
    Tischoff I; Tannapfel A
    Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined hepatocellular carcinoma and cholangiocarcinoma with components of mucinous carcinoma arising in a cirrhotic liver.
    Morita D; Kagata Y; Ogata S; Tsuda H; Hatsuse K; Mochizuki H; Matsubara O
    Pathol Int; 2006 Apr; 56(4):222-6. PubMed ID: 16634969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [CT and MR imaging differences between intrahepatic cholangiocarcinoma and hepatocellular carcinoma with invasions to billary tracts].
    Yang NJ; Song B; Wu B; Xu J; Zhao LM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):525-8. PubMed ID: 19627020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Patterns of bile duct invasion in hepatocellular carcinoma].
    Itoh S; Furukawa M; Nakata T; Yamada R; Maeda S; Morinaga T; Minamino T; Satoh A; Koga M; Yano M
    Nihon Gan Chiryo Gakkai Shi; 1983 Aug; 18(5):1160-6. PubMed ID: 6319510
    [No Abstract]   [Full Text] [Related]  

  • 37. Combined hepatocellular cholangiocarcinoma: prognostic factors investigated by computed tomography/magnetic resonance imaging.
    Lin G; Toh CH; Wu RC; Ko SF; Ng SH; Chou WC; Tseng JH
    Int J Clin Pract; 2008 Aug; 62(8):1199-205. PubMed ID: 17537192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathologic Characteristics of Hepatocellular Carcinoma With Reactive Ductule-like Components, a Subset of Liver Cancer Currently Classified as Combined Hepatocellular-Cholangiocarcinoma With Stem-Cell Features, Typical Subtype.
    Shibahara J; Hayashi A; Misumi K; Sakamoto Y; Arita J; Hasegawa K; Kokudo N; Fukayama M
    Am J Surg Pathol; 2016 May; 40(5):608-16. PubMed ID: 26735856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Classification of degree of liver damage and cancer stage].
    Yamasaki S
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():222-6. PubMed ID: 11761944
    [No Abstract]   [Full Text] [Related]  

  • 40. The value of gadobenate dimeglumine-enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma.
    Jeon TY; Kim SH; Lee WJ; Lim HK
    Abdom Imaging; 2010 Jun; 35(3):337-45. PubMed ID: 19350315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.